alpha-aminopyridine has been researched along with Complications, Pregnancy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esther, CR; McKinzie, C; Stringer, E; Terrell, M; Trimble, A | 1 |
| Aitken, ML; Godfrey, EM; Heltshe, SL; Josephy, T; Taylor-Cousar, JL | 1 |
2 other study(ies) available for alpha-aminopyridine and Complications, Pregnancy
| Article | Year |
|---|---|
Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding.
Topics: Adult; Aminophenols; Aminopyridines; Benzodioxoles; Breast Feeding; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Drug Monitoring; Female; Fetal Blood; Humans; Infant, Newborn; Liver Function Tests; Milk, Human; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Quinolones; Treatment Outcome | 2018 |
Pregnancy among cystic fibrosis women in the era of CFTR modulators.
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Rate; Pregnancy, High-Risk; Quinolones; Risk Adjustment; United States | 2017 |